Advertisement

Vasopeptides pp 197-208 | Cite as

Participation of Kinins in the Regulation of Cerebral Vasopermeability

  • G. Seidel
  • U. Wendel
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 21)

Abstract

With numerous experiments the role of kinins has been studied in inflammation with increased vasopermeability, for instance after turpentine injection into pleural cavity, injection of kaolin, serotonin, carrageenin or polyvinylpyrolidon into rat paws and after thermal injury or exposure to ultra-violet irradiation (for review:Bonta, 1969; Kellermeyer and Graham, 1968). obviously the significance of kinins is limited to local physiological and/or pathophysiological conditions (Creutzfeld, 1969; ofstad, 1970).

Keywords

Evans Blue Cerebral Vessel Spontaneous Motility Cellulose Sulphate Plasmodium Knowlesi 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arrigoni Martelli, E., Corsico, N. and Fogagnolo, E.: Significance of the release of bradykinin in local inflammatory reactions and related effect of antiphlogistic drugs; in A.Bertelli and J.C.Houck (Eds.), Inflammation biochemistry and drug interaction, p. 185–196. Excerpta Medica, Amsterdam (1969)Google Scholar
  2. Athanasoulis, C.A., Ferris, E.J. and Shapiro, J.H.: Bradykinin in cerebral angiography: Experimental observations in monkeys. Invest. Radiol. 4, 323–326 (1969).PubMedCrossRefGoogle Scholar
  3. Bonta, I.L.: Microvascular lesions as a target of anti-inflammatory and certain other drugs. Acta Physiol. Pharmacol. Neerl. 12, 188–222 (1969).Google Scholar
  4. Carpi, A. and Pinto Corrado, A.: Cerebral vascular action of bradykinin in the dog. Experientia 17, 326–327 (1961).PubMedCrossRefGoogle Scholar
  5. Creutzfeld, W.: Kininfreisetzung bei Pankreatitis; in G.L.Haberland, P.Matis (Eds.), Neue Aspekte der Trasylol-Therapie 3, p. 89–101 FK. Schattauer Verlag, Stuttgart (1969).Google Scholar
  6. Csanda, E., Földi, M., Obâl, F. and Zoltân, Ö.T.: Cerebral oedema as a consequence of experimental cervical lymphatic blockage. Angiologica 5, 55–63 (1968).PubMedGoogle Scholar
  7. Csillik, B. and Földi, M.: Severe alterations in myelin structure in experimental lymphogenous encephalopathy. Experientia 23, 835–836 (1967).PubMedCrossRefGoogle Scholar
  8. Dawson, W., Starr, M.S. and West, G.B.: Inhibition of anaphylactic shock in the rat by antihistamines and ascorbic acid. Br.J.Pharmac.Chemother. 27, 249–255 (1966).Google Scholar
  9. Eisen, V. and Loveday, C.: Effect of cellulose sulphate on serum complement. Br.J.Pharmac. 39, 831–833 (1970). -Google Scholar
  10. Földi, M.: Die Rolle der Lynrphzirkulation im Säftekreislauf des Auges und des Zentralnervensystems. Arch.Kreislaufforsch. 41, 186–212 (1963).CrossRefGoogle Scholar
  11. Földi, M.: Csillik, B., Job, F. and Zoltân, Ö.T.: Electron microscopic alterations in the central nervous system in experimental lymphogenic encephalopathy I. Angiologica 4, 50–56 (1967).PubMedGoogle Scholar
  12. Iwata, H., Shikimi, T. and Oka, T.: Pharmacological significances of peptidase and proteinase in the brain (report I)–enzymatic inactivation of bradykinin in rat brain. Biochem. Pharmacol. 18, 119–128 (1969).PubMedCrossRefGoogle Scholar
  13. Jo6, F.,Takâcs, 6., Varga, L., Domjân, G., Börcsök, Ethel, Rott, Susan, Rosta, Margit, Zoltân, Ö.T., Csillik, B. and Földi, M.: Collapse of the blood brain barrier in lymphostatic cerebral hemangiopathy and in triethyltin poisoning. Med. Exp. 19, 342–350 (1969).Google Scholar
  14. Kellermeyer, R.W. and Graham, R.C.: Kinins possiiile physiologic and pathologic roles in man. New England J.Med. 279, 754–759; 802–807; 859–866 (1968).Google Scholar
  15. Lewis, G.P.: Physiologically active peptides and vascular permeability. Thrombos. Diathes.Haemorrh.(Stuttg) Suppl. 40, 225–229 (1970).Google Scholar
  16. Ofstad, E.: Formation and destruction of plasma kinins during experimental acute hemorrhagic pancreatitis in dogs. Scand.J. Gastroent. 5, Suppl. 5 (1970).Google Scholar
  17. Onabanjo, A.O., Bhabani, A.R. and Maegraith, B.G. The significance of kinin-destroying enzymes activity in plasmodium knowlesi malarial infection. Br.J.Exp.Path. 51, 534–540 (1970).Google Scholar
  18. Ratnoff, 0.D.: Some relationships among hemostasis, fibrinolytic phenomena, immunity, and the inflammatory response. Advan.Immunol. 10, 145–227 (1969).CrossRefGoogle Scholar
  19. Rothschild, A.M.: Pharmacodynamic properties of cellulose sulfate and related polysaccharides - a group of bradykinin-releasing compounds; in M.Rocha e Silva, H.Rothschild (Eds.), International Symposium on Vasoactive Polypeptides: Bradykinin and related kinins, p. 197–203. Sao Paulo (1966).Google Scholar
  20. Rothschild, A.M.:Some pharmacodynamic properties of cellulose sulphate, a kininogen-depleting agent in the rat. Br.J.Pharmac. Chemother. 33, 501–512 (1968).Google Scholar
  21. Sicuteri, F., Fanciullacci, M., Bavazzano, A., Franchi, G. and Del Bianco, P.L.: Kinins and intracranial hemorrhages. Angiology 21, 193–210 (1970).PubMedCrossRefGoogle Scholar
  22. Starr, M.S.: Inability of dextran to release kinin in rats. J.Pharmac. Pharmacol. 22, 139–140 (1970).CrossRefGoogle Scholar
  23. Urbanitz, U., Wiegand, H. and Habermann, E.: Zur Frage der Bedeutung des Kininsystems beim thermischen Ödem der Rattenpfote. Naunyn-Schmiedebergs Arch. Pharmak. 246, 476–493 (1969).Google Scholar
  24. Varkonyi, T., Jó, F., Csillik, B., Zoltan, Ö.T. and Földi, M.: Increased permeability of the bloodbrain barrier in lymphostatic encephalopathy. Angiologica 6, 275–279 (1969).PubMedGoogle Scholar
  25. Vogel, R., Trautschold, I. and Werle, E.: Natürliche Proteinasen-Inhibitoren. Georg Thieme Verlag, Stuttgart (1966).Google Scholar
  26. Watters, J.W.: The effects of bradykinin and histamine on cerebral arterjes of monkeys. Radiology 98, 299–304 (1971).PubMedGoogle Scholar
  27. Werle, E. and Vogel, R.: Über die Freisetzung einer kallikreinartigen Substanz aus Extrakten verschiedener Organe (1). Arch. int. pharmacodyn. 131, 257–261 (1961).PubMedGoogle Scholar
  28. Wilhelm, D.L.: Kinins in human disease. Ann.Rev.Med. 22, 63–84 (1971).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1972

Authors and Affiliations

  • G. Seidel
    • 1
  • U. Wendel
    • 1
  1. 1.Department of Biochemical PharmacologyMax-Planck-Institut für experimentelle Medizin34 GöttingenGermany

Personalised recommendations